The Role of P53 in Sepsis-Induced Cardiomyopathy

1. Dantes RB, Epstein L. Combatting Sepsis: A Public Health Perspective. Clin Infect Dis. 2018,67(8):1300-1302. https://doi.org/10.1093/cid/ciy342. PMID: 29846544; PMCID: PMC6557150.10.1093/cid/ciy342655715029846544 Search in Google Scholar

2. Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017;377:414-417. https://doi.org/10.1056/NEJMp1707170.10.1056/NEJMp170717028658587 Search in Google Scholar

3. Judea Pusta CT, Bungau S, Buhas CL, Popa AR, Vesa CM, Buhas BA, Bardaca (Urducea) C, Tit DM, Daim MA, Judea AS: Experimental Study Upon the Virulence of Infectious Microbial Agents Involved in Violent Deaths Presenting Septic States. Rev Chim. 2019;70(8):2720-2726. https://doi.org/10.37358/RC.19.8.7415.10.37358/RC.19.8.7415 Search in Google Scholar

4. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. https://doi.org/10.1001/jama.2016.0287. PMID: 26903338 PMCID: PMC4968574.10.1001/jama.2016.0287496857426903338 Search in Google Scholar

5. Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM. Septic cardiomyopathy. Crit Care Med. 2018;46:625-634. doi:10.1097/CCM.0000000000002851.10.1097/CCM.000000000000285129227368 Search in Google Scholar

6. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483-490. https://doi.org/10.7326/0003-4819-100-4-483.10.7326/0003-4819-100-4-4836703540 Search in Google Scholar

7. Reil PM, Maghiar TT, Seidl K, Borza C, Nunkoo V, Buhas CL, Bungau S, Stanescu AMA, Pop OL, Judea Pusta CT. The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy. Rev Chim. 2019;70(11):3842-3846.10.37358/RC.19.11.7656 Search in Google Scholar

8. Sun X, Dai Y, Tan G, Liu Y, Li N. Integration analysis of m(6)A-SNPs and eQTLs associated with sepsis reveals platelet degranulation and staphylococcus aureus infection are mediated by m(6)A mRNA methylation. Front Genet. 2020;11:7.10.3389/fgene.2020.00007705445732174955 Search in Google Scholar

9. Parrillo JE. The cardiovascular pathophysiology of sepsis. Annu Rev Med. 1989;40:469-485. doi: 10.1146/annurev.me.40.020189.002345.10.1146/annurev.me.40.020189.0023452658761 Search in Google Scholar

10. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, Zhu L, Chittenden T. Proc. Natl. Acad. Sci. USA. 2001;98(20):11318.10.1073/pnas.2012087985872711572983 Search in Google Scholar

11. Nakano K, Vousden KH. Mol. Cell, 7, No. 3; 2001. p. 683.10.1016/S1097-2765(01)00214-3 Search in Google Scholar

12. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, Maclean KH, et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways, Cancer Cell. 2003;4(4):321. Search in Google Scholar

13. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock, G, Ausserlechner MJ, Adams JM. Strasser, p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa, A. Science. 2003;302(5647):1036.10.1126/science.109007214500851 Search in Google Scholar

14. Weber JD, Zambetti GP. Renewing The Debate Over The p53 Apoptotic Response, Cell Death Differ. 2003;10(4):409. Search in Google Scholar

15. Garrison SP, Thornton JA, Hacker H, Webby R, Rehg JE, Parganas E, Zambetti GP, Tuomanen EI. The p53 Target Puma Drives Neutrophil-mediated Protection Against Bacterial Lethal Sepsis, PloS Pathog. 2010;6(12):e1001240.10.1371/journal.ppat.1001240300960221203486 Search in Google Scholar

16. Reil P, Maghiar T, Seidl K, Borza C, Nunkoo V, Buhas C, Bungau S, Stănescu A, Pop O, Judea-Pusta C. The Role of BCL2 Protein and Tumour Protein p53 in Septic Cardiomyopathy. Revista de Chimie-Bucharest- Original Edition. 2019;70:3843-6.10.37358/RC.19.11.7656 Search in Google Scholar

17. Buerke U, Carter JM, Schlitt A, Russ M, Schmidt H, Sibelius U Grandel U, Grimminger F, Seeger W, Mueller-Werdan U, Werdan K, Buerke M: Apoptosis contributes to septic cardiomyopathy and is improved by simvastatin therapy. Shock. 2008;29:497-503.10.1097/SHK.0b013e318142c43418598004 Search in Google Scholar

18. Coopersmith CM, Stromberg PE, Davis CG, Dunne WM, Amiot DM 2nd, Karl IE, Hotchkiss RS, Buchman TG: Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest. Crit Care Med. 2003;31:1630-1637.10.1097/01.CCM.0000055385.29232.1112794397 Search in Google Scholar

19. Garrison SP, Thornton JA, Hacker H, Webby R, Rehg JE, Parganas E, Zambetti GP, Tuomanen EI: The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsis. PLoS Pathog 2010;DOI: 10.1371/journal.ppat.1001240.10.1371/journal.ppat.1001240 Search in Google Scholar

20. Zhang H, Xu C, -F, Ren C, Wu T, -T, Dong N, Yao Y, -M: Novel Role of p53 in Septic Immunosuppression: Involvement in Loss and Dysfunction of CD4+T Lymphocytes. Cell Physiol Biochem. 2018;51:452-469. DOI: 10.1159/000495241.10.1159/00049524130453300 Search in Google Scholar